½ÃÀ庸°í¼­
»óǰÄÚµå
1589003

¼¼°èÀÇ ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå

Smart Insulin Pens and Pumps

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 89 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 92¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â 52¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ¼¼°è ½ÃÀåÀº 2023-2030³â ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 8.6% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 92¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½º¸¶Æ® Àν¶¸° ÆßÇÁ´Â CAGR 8.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 79¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½º¸¶Æ® Àν¶¸° Ææ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 12.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 14¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.2%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀº 2023³â 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023-2030³â ºÐ¼® ±â°£ µ¿¾È 8.2%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â±îÁö 14¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ºÐ¼® ±â°£ µ¿¾È °¢°¢ 8.1%¿Í 7.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 7.0%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃßÁø ¿äÀÎ ¿ä¾à

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ´Â ¾î¶»°Ô ´ç´¢º´ °ü¸®¸¦ °­È­Çϴ°¡?

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ´Â Á¤È®ÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ°í ¸ÂÃãÇü Àν¶¸° Åõ¿©¸¦ ÅëÇØ ´ç´¢º´ °ü¸®¸¦ °³¼±Çϵµ·Ï ¼³°èµÈ ÷´Ü ÀÇ·á±â±âÀÔ´Ï´Ù. ½º¸¶Æ® ÆæÀº ÃøÁ¤µÈ ¾çÀÇ Àν¶¸°À» °ø±ÞÇϰí, ½º¸¶Æ® ÆßÇÁ´Â »ç¿ëÀÚÀÇ Æ÷µµ´ç ¼öÄ¡¿¡ µû¶ó Áö¼ÓÀûÀ¸·Î ÇÇÇÏ Àν¶¸°À» ÁÖÀÔÇÕ´Ï´Ù. ÀÌ ±â±âµéÀº ºí·çÅõ½º ¿¬°á, ¿ë·® ÃßÀû, ¸ð¹ÙÀÏ ¾Û°úÀÇ ÅëÇÕ µîÀÇ ±â´ÉÀ» °®Ãß°í ÀÖ¾î »ç¿ëÀÚ°¡ Àν¶¸° »ç¿ë·®À» Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇϰí Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ´Â ¸ÂÃãÇü Ä¡·á¸¦ Áö¿øÇϰí ÇÕº´Áõ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á Á¦ 1Çü ¹× Á¦ 2Çü ´ç´¢º´ ȯÀÚÀÇ ´ç´¢º´ Ä¡·á¸¦ º¯È­½Ã۰í ÀÖ½À´Ï´Ù.

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº ¹«¾ùÀΰ¡?

ÁÖ¿ä Á¦Ç° À¯ÇüÀ¸·Î´Â ½º¸¶Æ® Àν¶¸° Ææ, ½º¸¶Æ® Àν¶¸° ÆßÇÁ, Ä¿³ØÆ¼µå Àν¶¸° ĸ µîÀÌ ÀÖÀ¸¸ç, ½º¸¶Æ® Àν¶¸° ÆßÇÁ´Â ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM)À» Áö¿øÇÏ¿© Àν¶¸° Åõ¿©¸¦ ÀÚµ¿È­ÇÒ ¼ö ÀÖ¾î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿ëµµ´Â Á¦1Çü ´ç´¢º´°ú Á¦2Çü ´ç´¢º´À̸ç, Á¦1Çü ´ç´¢º´ ȯÀÚ´Â ÀϰüµÈ Àν¶¸° °ü¸®°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ Á¦1Çü ´ç´¢º´ÀÌ Áß¿äÇÑ ºÎ¹®À» Â÷ÁöÇÕ´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡´Â º´¿ø, Ŭ¸®´Ð, ÀçÅà ÀÇ·á°¡ Æ÷ÇԵǸç, ÀçÅà ÀÇ·á´Â ´ç´¢º´ ȯÀÚÀÇ ÀÚ°¡ °ü¸® µµ±¸ äÅà Áõ°¡·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½º¸¶Æ® Àν¶¸° ÀåÄ¡´Â ´ç´¢º´ Ä¡·á¿¡ ¾î¶»°Ô ÅëÇյǾî Àִ°¡?

½º¸¶Æ® Àν¶¸° ÆæÀº º¹¿ë·® ±â¾ï, º¹¿ë·® ±ÇÀå, º¹¿ë·® ´©¶ô ¾Ë¸² ±â´ÉÀ» °®Ãß°í ÀÖ¾î »ç¿ëÀÚ°¡ ½Ä»ç ½Ã°£°ú º¸Á¤ Àν¶¸°À» È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ½º¸¶Æ® ÆßÇÁ´Â Á¾Á¾ ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ(CGM) ½Ã½ºÅÛ°ú ÅëÇյǾî Ç÷´ç ÃøÁ¤ °ªÀ» ±â¹ÝÀ¸·Î Àν¶¸° Åõ¿©·®À» ÀÚµ¿À¸·Î Á¶Á¤ÇÏ¿© ¾ÈÁ¤ÀûÀÎ Ç÷´ç ¼öÄ¡¸¦ Áö¿øÇÕ´Ï´Ù. º´¿ø°ú Ŭ¸®´Ð¿¡¼­ ÀÌ·¯ÇÑ ±â±â´Â Àν¶¸° Ä¡·á °á°ú¸¦ °³¼±ÇÏ°í ½Ç¼ö¸¦ ÁÙÀ̸ç ȯÀÚ ¸ð´ÏÅ͸µÀ» À§ÇØ ÀÇ·á Àü¹®°¡¿¡°Ô ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, Àç°¡ ȯÀÚµéÀº ½º¸¶Æ® Ææ ¹× ÆßÇÁ¿Í ¿¬µ¿µÈ ¸ð¹ÙÀÏ ¾ÛÀ» »ç¿ëÇÏ¿© Àν¶¸° »ç¿ë·®À» ÃßÀûÇϰí, Ç÷´ç ÃßÀ̸¦ È®ÀÎÇϰí, ¸ÂÃãÇü Ä¡·á Á¶Á¤À» ¹Þ°í, ´õ ³ªÀº ÀÚ°¡ °ü¸® ¹× ¼øÀÀµµ¸¦ Áö¿øÇÕ´Ï´Ù.

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁ ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, º¸´Ù È¿°úÀûÀÎ Àν¶¸° °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿¬°á¼º, Åõ¾à Á¤È®µµ, CGM ÅëÇÕ°ú °°Àº ±â±â ±â¼úÀÇ ¹ßÀüÀº »ç¿ëÀÚÀÇ ÆíÀǼº°ú Ä¡·á °á°ú¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ´ç´¢º´ Ä¡·á¿¡¼­ ¸ÂÃãÇü ÀÇ·á¿Í ÀÚ°¡ °ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½º¸¶Æ® Àν¶¸° ±â±âÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ ¹× ¸¸¼ºÁúȯ °ü¸®¸¦ ÃËÁøÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â ȯÀÚµéÀÇ »îÀÇ ÁúÀ» °³¼±Çϱâ À§ÇÑ Ã·´Ü ¼Ö·ç¼ÇÀ» ã´Â ȯÀÚµéÀÇ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ º´¿ø ÀçÀÔ¿øÀ» ÁÙÀ̰í ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ´Â °Íµµ ½º¸¶Æ® Àν¶¸° Ææ ¹× ÆßÇÁÀÇ º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÁÖ¸ñ 33°³»ç)

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ¼ºÀå ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

ksm 24.11.18

Global Smart Insulin Pens and Pumps Market to Reach US$9.2 Billion by 2030

The global market for Smart Insulin Pens and Pumps estimated at US$5.2 Billion in the year 2023, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Smart Insulin Pens segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Smart Insulin Pens and Pumps Market - Key Trends and Drivers Summarized

How Are Smart Insulin Pens and Pumps Enhancing Diabetes Management?

Smart insulin pens and pumps are advanced medical devices designed to improve diabetes management by providing accurate, real-time data and personalized insulin delivery. Smart pens deliver insulin in measured doses, while smart pumps provide continuous subcutaneous insulin infusion based on the user's glucose levels. These devices offer features like Bluetooth connectivity, dose tracking, and integration with mobile apps, enabling users to monitor and adjust insulin usage with precision. By supporting personalized therapy and reducing the risk of complications, smart insulin pens and pumps are transforming diabetes care for both Type 1 and Type 2 diabetics.

What Are the Key Segments in the Smart Insulin Pens and Pumps Market?

Key product types include smart insulin pens, smart insulin pumps, and connected insulin caps, with smart insulin pumps holding the largest market share due to their continuous glucose monitoring (CGM) compatibility and ability to automate insulin delivery. Major applications cover Type 1 and Type 2 diabetes, with Type 1 diabetes representing a significant segment as these patients require consistent insulin management. End-users include hospitals, clinics, and home care, with home care leading the market due to the increasing adoption of self-management tools by diabetic patients.

How Are Smart Insulin Devices Integrated Across Diabetes Care?

Smart insulin pens are equipped with dose memory, dose recommendations, and missed dose alerts, helping users manage mealtime and correction insulin effectively. Smart pumps, often integrated with continuous glucose monitoring (CGM) systems, automatically adjust insulin delivery based on glucose readings, supporting stable blood sugar levels. In hospitals and clinics, these devices are used to improve insulin therapy outcomes, reduce errors, and provide real-time data to healthcare professionals for patient monitoring. Additionally, home care patients use mobile apps linked to smart pens and pumps to track insulin usage, review glucose trends, and receive personalized therapy adjustments, supporting better self-care and adherence.

What Factors Are Driving the Growth in the Smart Insulin Pens and Pumps Market?

The growth in the Smart Insulin Pens and Pumps market is driven by several factors, including increasing diabetes prevalence, which has heightened the need for more effective insulin management solutions. Advancements in device technology, such as improved connectivity, dose accuracy, and CGM integration, have enhanced user convenience and therapy outcomes. The rising focus on personalized medicine and self-management in diabetes care has accelerated the adoption of smart insulin devices. Government initiatives promoting digital health and chronic disease management have further fueled demand, as patients seek advanced solutions to improve quality of life. Additionally, healthcare providers’ focus on reducing hospital readmissions and improving patient outcomes has contributed to the widespread adoption of smart insulin pens and pumps.

Select Competitors (Total 33 Featured) -

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Smart Insulin Pens and Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Spurs Demand for Smart Insulin Pens and Pumps
    • Technological Advancements in Real-Time Glucose Monitoring and Automated Insulin Delivery Drive Adoption
    • Growing Focus on Personalized Diabetes Management Expands Addressable Market for Smart Insulin Devices
    • Expansion of Smart Insulin Solutions in Home Healthcare and Remote Patient Monitoring Fuels Market Growth
    • Increasing Demand for Accurate Dosing, Safety Alerts, and Predictive Analytics Drives Adoption
    • Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics Strengthens Business Case
    • Rising Focus on Patient Adherence, Dosage Tracking, and Data-Driven Insights Accelerates Demand
    • Technological Innovations in Needle-Free Insulin Delivery and Wearable Infusion Pumps Propel Market Growth
    • Growing Use of Smart Insulin Devices in Pediatrics, Geriatrics, and Special Populations Drives Adoption
    • Focus on Achieving Seamless Integration with Telehealth Platforms Expands Addressable Market
    • Technological Advancements in Long-Lasting Battery, Compact Design, and Bluetooth Connectivity Propel Growth
    • Rising Demand for Cost-Effective, Reusable, and Disposable Smart Insulin Devices Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Smart Insulin Pens and Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • JAPAN
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CHINA
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • EUROPE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • FRANCE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • GERMANY
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • UNITED KINGDOM
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦